{"id":"W2163830908","doi":"10.1056/nejmoa074941","title":"Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":1995,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"Savient Pharmaceuticals; Novo Nordisk; Sanofi; Servier; Amgen; Pfizer; National Institute on Aging; Eli Lilly and Company; GlaxoSmithKline","keywords":"Zoledronic acid; Medicine; Placebo; Adverse effect; Hip fracture; Surgery; Internal medicine; Osteoporosis; myalgia; Bisphosphonate; Osteonecrosis of the jaw","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02106212802403476,"score_gpt":0.3676463706884712,"score_spread":0.3465842426644364,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}